Switzerland to accept medical devices certified by the FDA
The Swiss parliament made an urgent and necessary decision paving the way for accepting medical devices certified by the FDA.
FDA rejects Verily’s smartwatch-based Parkinson’s clinical trial tool
The FDA issued a letter to the company declaring that it will not accept a letter of intent for the company's Parkinson's exam.
FDA greenlights Ellume COVID-19 Home Test
The test demonstrated 96% accuracy in a multi-site US clinical study of both adults and children 2 years and above.
FDA launches the Digital Health Center of Excellence
It is an important step in furthering the agency's overarching dedication to the advancement of digital health technology.
FDA’s new app lets physicians report novel uses of existing medicines
CURE ID allows the clinical community to report their experiences treating difficult-to-treat infectious diseases with novel uses of existing drugs.
FDA unveils a framework for reviewing AI-based medical devices
The agency has released a discussion paper detailing how it plans to vet and approve AI medical devices without compromising quality or patient safety.
AliveCor’s bloodless hyperkalemia test scores the “Breakthrough Device” designation from the FDA
This means that the agency will consider AliveCor's technology on an accelerated clearance track.
FDA selects 9 companies for its precertification pilot
The list includes Apple, Fitbit, Johnson & Johnson, Pear Therapeutics, Phosphorus, Roche, Samsung, Tidepool and Verily.
FDA looking for digital health innovators for an entrepreneur-in-residence program
The initiative is designed to support and help develop FDA's Software Precertification (PreCert) Pilot Program.
FDA’s digital health pre-certification pilot program is now open for applications
The focus of the Pre-Cert program is not on particular products but on firms and developers, which in turn (if pre-certified) will be able to more easily certify all of their products.